Joint AES/ILAE translational workshop to optimize preclinical epilepsy research

Epilepsia

Volumn 54, Issue SUPPL.4, 2013, Pages 1-2

  Galanopoulou, Aristea S ^a   Simonato, Michele ^b,c   French, Jacqueline A ^d   O'Brien, Terence J ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

^c National Institute of Neuroscience   (Italy)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; NEW DRUG;

DRUG DEVELOPMENT; DRUG RESISTANCE; DRUG SCREENING; EDITORIAL; EDUCATION; EPILEPSY; HUMAN; MEDICAL SOCIETY; TRANSLATIONAL RESEARCH;

ANTICONVULSANTS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; DRUGS, INVESTIGATIONAL; EDUCATION; EPILEPSY; HUMANS; SOCIETIES, MEDICAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84891701056     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12293     Document Type: Editorial

References (1)

1. Galanopoulou AS, Buckmaster PS, Staley KJ, Moshe SL, Perucca E, Engel J Jr, Loscher W, Noebels JL, Pitkanen A, Stables J, White HS, O'Brien TJ, Simonato M., American Epilepsy Society Basic Science Committee And The International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug Discovery (2012) Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia 53:571-582.